Sage Journals: Discover world-class research

Retricted access

Research article

First published 1994-12

Cep Regimen (Ccnu,Etoposide,Prednimustine) for Relapsed/Refractory Hodgkin's Disease

Pier Luigi Zinzani, Enza Barbieri, Maurizio Bendandi [...]

Tumori Journal

Retricted access

Research article

First published 2019-11

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy

Anat Achiron, Ida Sarova-Pinhas, David Magalashvili [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2024

Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China

Jun Guo, Jiayong Wu, Lihua Wang [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2026

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors

Wei Zhen Yeh, Fiona Chan, Anna Francis [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2017-3

Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing–remitting multiple sclerosis patients

J Nicholas, JJ Ko, Y Park [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 1992-9

Relapse of Graves' Disease Following Development of a Pheochromocytoma

R. Paschke, I. Enger, I. Harsch [...]

Thyroid®

Retricted access

Research article

First published 2015-4

Increased anti-KIR4.1 antibodies in multiple sclerosis: Could it be a marker of disease relapse?

Livnat Brill, Lotem Goldberg, Arnon Karni [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1998-08

Relapse of Graves' Disease After Subacute Thyroiditis

Fabienne Grunenberger, Marie Pierre Chenard, Jean Christophe Weber [...]

Thyroid®

Open access

Research article

First published 2018-1

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

Eva Havrdová, Douglas L Arnold, Amit Bar-Or [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2025-7

Relapse or no relapse in multiple sclerosis: Can disease activity biomarkers support the clinician?

Jeske van Pamelen, Marleen J A Koel-Simmelink, Birgit I Lissenberg [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Search results